http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6747128-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae5eeab009d7a713b1c670c679cc667 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 1997-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b464fff064539f3d1c8b5bde934f7ee4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e94dad3d1c629a8c97f929d6700947d |
| publicationDate | 2004-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6747128-B2 |
| titleOfInvention | Components of ubiquitin ligase complexes, and uses related thereto |
| abstract | The present invention relates to the isolation of a new class of ubiquitin ligases involved in protein degradation in vertebrate organisms, such as protein degradation of cell cycle regulatory proteins. Accordingly, the invention provides nucleic acids and the proteins encoded by said nucleic acids which play a role in the ubiquitinylation and subsequent degradation of substrate proteins and in regulating cell proliferation, cell differentiation, and cell survival. The invention also provides methods for modulating protein degradation, cell proliferation, cell differentiation and/or cell survival by modulating protein ubiquitination; assays for identifying compounds which modulate protein degradation, cell proliferation, differentiation and/or cell survival; methods for treating disorders associated with aberrant protein degradation, cell proliferation, cell differentiation, and/or cell survival; and diagnostic and prognostic assays for determining whether a subject is at risk of developing a disorder associated with an aberrant protein degradation, cell proliferation, cell differentiation, and/or survival. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006044747-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101781674-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010099096-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194262-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008106087-A1 |
| priorityDate | 1997-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.